Skip to main content
. 2023 Dec 23;41:e00826. doi: 10.1016/j.btre.2023.e00826

Fig. 3.

Fig 3

The binding activity of the plant-produced RSV-F Fc fusion protein to Motavizumab (anti-RSV mAb) was analyzed by ELISA. The plant-produced RBD-Fc was used as a negative control. Data are presented as mean ± SD of triplicates.